The cause of multiple sclerosis is not well understood. In fact, it’s not understood at all, explained June Halper, MSN, APN-C, MSCN, FAAN, chief executive officer, Consortium of Multiple Sclerosis Centers.
The cause of multiple sclerosis is not well understood. In fact, it’s not understood at all, explained June Halper, MSN, APN-C, MSCN, FAAN, chief executive officer, Consortium of Multiple Sclerosis Centers.
Has there been any recent progress in understanding causes behind multiple sclerosis?
The cause of MS [multiple sclerosis] is not well understood. In fact, it’s not understood at all. There are some theories that have popped up over the years. Many years ago they talked about a canine distemper virus. In other years, they talked about other problems like Esptein-Barr virus. But, so far nothing has been discovered that actually triggers off MS. More and more, investigators are looking into genetics. MS is not a hereditary disease, but it seems to occur more frequently in certain families. So, families are being studied. Certainly, genetic profiles are being studied. There’s a doctor, Sergio Baranzini, PhD, professor in residence of Neurology at the University of California, San Francisco Institute for Human Genetics, who just spoke at our annual meeting out in Seattle, who is doing a lot of interesting work in genetics. Probably in the next few years, we may start seeing more and more information about risks for MS—high risk versus low risk. Certain medications that might be more appropriate for someone based on a genetic profile.
We know that in people as they age in MS, things change. So, we’re not sure if the disease occurs later in life, will it be different than if it occurs in a child because there are pediatric MS cases now. I think with the technology we have and the wisdom that’s out there in the community, we will see some more answers, but right now, no, unfortunately.
New Insights Into Meth-Associated PAH Care Gaps: Anjali Vaidya, MD, on Closing the Divide
June 4th 2025Research from Anjali Vaidya, MD, FACC, FASE, FACP, Temple University Hospital, reveals critical care gaps for patients with methamphetamine-associated pulmonary arterial hypertension (PAH), emphasizing the need for early diagnosis and integrated support.
Read More
Laundromats as a New Frontier in Community Health, Medicaid Outreach
May 29th 2025Lindsey Leininger, PhD, and Allister Chang, MPA, highlight the potential of laundromats as accessible, community-based settings to support Medicaid outreach, foster trust, and connect families with essential health and social services.
Listen
Tailored Dosing for MM Matters More Than Drug Count: Ajai Chari, MD
April 25th 2025When it comes to treating multiple myeloma (MM), Ajai Chari, MD, argued that more is not always better. More intense treatment regimens, or those with more drugs, don't necessarily guarantee better outcomes.
Read More
What's at Stake as Oral Arguments Are Presented in the Braidwood Case? Q&A With Richard Hughes IV
April 21st 2025Richard Hughes IV, JD, MPH, spoke about the upcoming oral arguments to be presented to the Supreme Court regarding the Braidwood case, which would determine how preventive services are guaranteed insurance coverage.
Read More